Latest "Starr Companies" News Stories

18:35 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "Starr Companies" found in our extensive news archives from over 250 global news sources.

More Information about Starr Companies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Starr Companies for you to read. Along with our medical data and news we also list Starr Companies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Starr Companies Companies for you to search.

Showing "Starr Companies" News Articles 1–25 of 5,200+

Tuesday 19th February 2019

Bausch Health Companies - The Little Engine That Could

Vocera to Present at 8th Annual SVB Leerink Global Healthcare Conference

Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, today announced that Justin Spencer, Chief Financial Officer, will be presenting at the 8th Annual SVB Leerink Global Healthcare Conference on Wednesday, Feb. 27, 2019 at 3:30 p.m. ET in New York City. The presentation will be avai...

Medtronic Receives FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management

DUBLIN - February 19, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Personalized Closed Loop (PCL) insulin pump system, currently in development. The PCL technology is designed to automate insulin delivery in a way that is real-time, per...

Nemus and Pharmaceuticals International look to THC

Companies have agreed to develop a sterile eye drop dosage formulation, based on a cannabinoid, for Glaucoma

Hardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked

Hardman & Co Research 19-Feb-2019 / 07:15 GMT/BST Hardman & Co: Transformed and de-risked Yourgene Health (YGEN) is an international molecular diagnostics group that uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests (NIPT). Its flagship IONA test uses complex statistical analyses to determine the likelihood that a fetus is carrying a gene...

Vistin Pharma ASA : Fourth quarter 2018 financial results

Oslo, Norway, 19 February 2019 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter of 2018 in line with the business updates from the company on 4 and 8 January 2019. The revenues for the fourth quarter 2018 ended at NOK 40.1 million (Q4 2017: NOK 41.3 million). The loss from continuing operations ended at NOK -56.4 million (-6.8...

Monday 18th February 2019

Two Pharma Companies File Chapter 11 Bankruptcy

The season surrounding Valentine’s Day brings out the love in many people, but for two pharma companies, this year was a year of heartbreak. California-based Aradigm Corporation and New Jersey-based Immune Pharmaceuticals both filed Chapter 11.

Self-driving cars have miles to go before they reach full autonomy, says watchdog

Companies such as Google’s Waymo are testing robot cars on Californian public roads, and reports to the Department of Motor...Read More... The post Self-driving cars have miles to go before they reach full autonomy, says watchdog appeared first on Pharmaceutical Technology.

Ten European Genomics Companies to Watch Out For

Next generation sequencing has revolutionized the biotech industry and genomics technology has changed dramatically over the last few years. There are many interesting European genomics companies, but here are 10 we thought especially worthy of mention. By 2025, the size of global genomics market is predicted to reach a whopping €24B, and unsurprisingly, there’s a […] The post Ten Europe...

Bayer Bags Full Vitrakvi Rights As Lilly Signs Off Loxo Buy

When buying Loxo, Lilly highlighted the importance of LOXO-292, a first-in-class oral RET inhibitor, rather than the already-approved Vitrakvi, perhaps...   

Troubled Realm Therapeutics Selling Assets, Delisting From London AIM

US-based, UK-listed biotech says it is talking with 'interested parties' including those considering making an offer for the business.   

Pipeline Watch: Phase III Starts In Prostate Cancer, C Diff Diarrhea

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...   

Finance Watch: 5AM, Longevity Close Funds, New Incubators Launch To Support Early-Stage Companies

News of 5AM's two latest venture funds follows the launch of Longevity Vision Fund as well as LA BioMed's and...    

Sunday 17th February 2019

Layoffs Hit California Biopharma Companies

January was a rough month for many pharma employees in California, as several companies pulled the trigger on layoffs, or announced coming layoffs that will affect hundreds of employees.

Friday 15th February 2019

Publix makes Fortune’s Best Companies to Work For list

Publix came in at No. 12 on Fortune’s list of the 100 Best Comp

Thursday 14th February 2019

MichBio Applauds the Fostering Innovation Act, A Bipartisan Bill Offering Continued Support to Emerging Bio Industry Companies

The Michigan Bioscience Industry Association, MichBio, along with organizations around the country, supports the recently introduced Fostering Innovation Act. The Act introduced by Sens. Gary Peters (D-MI), Thom Tillis (R-NC), David Perdue (R-GA), and Kyrsten Sinema (D-AZ) would build on the success of the JOBS Act by extending the exemption from ...

Patterson Companies Third-Quarter Fiscal 2019 Conference Call Scheduled for Thursday, February 28, 2019

Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2019 third-quarter conference call on Thursday, February 28, 2019 at 9 a.m. CT (10 a.m. ET). The company’s earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company’s websit...

Janssen Announces Preliminary Results from Phase 2 Study in Adults with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Pathway Defects

SAN FRANCISCO, Feb. 14, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson will present today at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) early results from the ongoing Phase 2 GALAHAD study evaluating niraparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in patients with metastatic castration-resistant prostate ...

Strategic Financial Solutions Donates Over $1,000 to the American Heart Association in Honor of Heart Awareness Month

Strategic Financial Solutions held its third annual Carnation Donation event to raise money for the American Heart Association (AHA) in honor of Heart Awareness Month. The company announced that it would sell $3 carnations to employee-owners and all proceeds would go to the AHA. All the money raised will be used to help fund innovative research for new treatments, provide programs and services for...

Worcester Polytechnic Institute Researchers Urge High-Tech Firms to Leverage Talents of Neurodiverse Workers

WPI researchers examine how technology companies can take steps to recognize and create inclusive strategies for workers with neurological variations, such as autism spectrum disorder. WORCESTER, Mass. (PRWEB) February 14, 2019 A newly published academic paper by Worcester Polytechnic Institute researchers says that high-tech firms need to take advantage of the talents of a growing neurodiverse w...

1stWEST M&A Just Published a Definitive, Book-Length Guide to Company Valuations, Mergers, and Acquisitions for Cannabis and Hemp Companies

Dr. Carl Craig and John D. Wagner’s New Book Offers 24 Short Chapters to Help Cannabis and Hemp Companies Through the M&A Process 1stWEST Mergers and Acquisitions today announced that two of its Managing Directors, Dr. Carl Craig and John D. Wagner, have published a definitive book to guide cannabis and hemp companies through every step of...

Fitwel® Announces an 80% increase in Certifications in One Year, Showing a Surging Trend in Building for Health

The Center for Active Design, operator of Fitwel, Recognizes 17 Industry Leaders Advancing Best in Building Health The Center for Active Design (CfAD) announces a sharp uptick in the application of the Fitwel Certification System, with an 80% increase in projects achieving certification between 2017 and 2018. Today, CfAD recognizes exceptional real est...

Global Medical Device Company Goes Live with Model N Revenue Cloud for MedTech, the Leading Cloud-Based Revenue Management System

Model N, Inc. (NYSE: MODN), the leader in cloud-based revenue management solutions today announced that it has partnered with ICU Medical (NASDAQ: ICUI)—a worldwide leader in the development, manufacture, and sale of medical devices—to modernize and combine that company’s legacy revenue systems in the cloud with Model N Revenue Cloud for MedTech. ...

Collaboration And Pay For Performance Deals – The Way To Pay for One-Off Treatments

New payment models, registries and the Cross Border Healthcare Directive could help determine new ways to pay for potentially...

Feedback Medical appoints radiologist and NHS England Clinical Entrepreneur Fellow as CEO

Cambridge, UK, 14 February 2019 - Feedback plc (AIM: FDBK, "Feedback", or the “Company”), the specialist medical imaging technology company, announces that its operating subsidiary, Feedback Medical Ltd, has appointed Dr Tom Oakley as its Chief Executive Officer. A qualified clinical radiologist, Dr Oakley has significant experience of successfully launching healthcare pr...

Quick Search


News Quicklinks